Elżbieta Nowara

1.4k total citations
70 papers, 1.0k citations indexed

About

Elżbieta Nowara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Elżbieta Nowara has authored 70 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Elżbieta Nowara's work include Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and BRCA gene mutations in cancer (9 papers). Elżbieta Nowara is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and BRCA gene mutations in cancer (9 papers). Elżbieta Nowara collaborates with scholars based in Poland, United States and Germany. Elżbieta Nowara's co-authors include Joanna Huszno, Magdalena Budryk, Zofia Kołosza, Martine Piccart, Jean-­Marc Ferrero, Igor Bondarenko, J. Bonneterre, Ahmad Awada, Ashish Bakshi and Josep Tabernero and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Elżbieta Nowara

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elżbieta Nowara Poland 18 526 359 220 173 156 70 1.0k
Elizabeth B. Somers United States 17 390 0.7× 357 1.0× 161 0.7× 214 1.2× 110 0.7× 28 1.1k
Xochiquetzal J. Geiger United States 17 450 0.9× 343 1.0× 259 1.2× 149 0.9× 161 1.0× 44 1.0k
Vamsi Parimi United States 17 279 0.5× 375 1.0× 176 0.8× 240 1.4× 80 0.5× 38 918
Dimitra Grapsa Greece 16 268 0.5× 224 0.6× 91 0.4× 139 0.8× 56 0.4× 76 838
Li‐Chun Lu Taiwan 22 419 0.8× 262 0.7× 170 0.8× 204 1.2× 153 1.0× 60 1.2k
E. Kutarska Poland 12 440 0.8× 274 0.8× 66 0.3× 96 0.6× 91 0.6× 17 939
Teresa Drudis Italy 8 531 1.0× 405 1.1× 435 2.0× 112 0.6× 140 0.9× 10 1.1k
Iori Kisu Japan 26 335 0.6× 448 1.2× 394 1.8× 103 0.6× 157 1.0× 89 1.7k
Mark Messing United States 13 420 0.8× 261 0.7× 100 0.5× 171 1.0× 160 1.0× 31 1.1k
Shin‐Wha Lee South Korea 21 284 0.5× 182 0.5× 167 0.8× 105 0.6× 80 0.5× 78 1.1k

Countries citing papers authored by Elżbieta Nowara

Since Specialization
Citations

This map shows the geographic impact of Elżbieta Nowara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elżbieta Nowara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elżbieta Nowara more than expected).

Fields of papers citing papers by Elżbieta Nowara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elżbieta Nowara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elżbieta Nowara. The network helps show where Elżbieta Nowara may publish in the future.

Co-authorship network of co-authors of Elżbieta Nowara

This figure shows the co-authorship network connecting the top 25 collaborators of Elżbieta Nowara. A scholar is included among the top collaborators of Elżbieta Nowara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elżbieta Nowara. Elżbieta Nowara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nowara, Elżbieta, et al.. (2025). Metastasis of Squamous Cell Carcinoma of the Larynx to the Right Adrenal Gland—A Case Report. Clinics and Practice. 15(3). 49–49.
2.
Malchrowicz-Mośko, Ewa, Mateusz Rozmiarek, J. Meller, et al.. (2025). COVID-19 Pandemic Conditions Affecting QoL and Mental Health of Oncology Patients in Poland. Cancers. 17(4). 662–662.
3.
Huszno, Joanna, Magdalena Budryk, Zofia Kołosza, et al.. (2016). A Comparison between <b><i>CHEK2</i></b>*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis. Oncology. 90(4). 193–198. 10 indexed citations
4.
Nowara, Elżbieta, et al.. (2016). Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia. Postępy Higieny i Medycyny Doświadczalnej. 70(0). 534–541. 10 indexed citations
5.
Deplanque, G., Martin Demarchi, Mohamed Hebbar, et al.. (2015). A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer. Annals of Oncology. 26(6). 1194–1200. 78 indexed citations
6.
Huszno, Joanna, et al.. (2015). The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab. Archives of Medical Science. 2(2). 371–377. 9 indexed citations
7.
Polakiewicz-Gilowska, Anna, et al.. (2015). Interstitial pneumonia during treatment with rituximab. 5(1). 16–20.
8.
Cutsem, Eric Van, Cathy Eng, Elżbieta Nowara, et al.. (2014). Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer. Clinical Cancer Research. 20(16). 4240–4250. 92 indexed citations
9.
Nowara, Elżbieta, et al.. (2014). Metaplastic breast carcinomas – analysis of prognostic factors in a case series. Współczesna Onkologia. 2(2). 116–119. 18 indexed citations
10.
Kaleta, Beata, et al.. (2014). Bewacyzumab w leczeniu pierwszej linii u chorej na potrójnie negatywnego raka piersi w stadium rozsiewu — opis przypadku i przegląd literatury. Nowotwory Journal of Oncology. 64(4). 321–326. 1 indexed citations
11.
Naumann, R. Wendel, Robert L. Coleman, Robert A. Burger, et al.. (2013). PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer. Journal of Clinical Oncology. 31(35). 4400–4406. 169 indexed citations
12.
Giebel, Sebastian, Tomasz Czerw, Maria Saduś‐Wojciechowska, et al.. (2013). Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. Bone Marrow Transplantation. 48(7). 915–921. 17 indexed citations
13.
Cohn, Allen Lee, Josep Tabernero, Joan Maurel, et al.. (2013). A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer. Annals of Oncology. 24(7). 1777–1785. 74 indexed citations
14.
Huszno, Joanna, et al.. (2012). Mucin secretion activity of gastric cancer as a prognostic factor: a clinicopathological analysis. Współczesna Onkologia. 2(2). 159–165. 7 indexed citations
15.
Cohn, Allen Lee, Josep Tabernero, Joan Maurel, et al.. (2012). Conatumumab (CON) plus FOLFIRI (F) or ganitumab (GAN) plus F for second-line treatment of mutant (MT) KRAS metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 30(4_suppl). 534–534. 3 indexed citations
16.
Eng, Cathy, Elżbieta Nowara, Anna Świeboda-Sadlej, et al.. (2011). PRIMARY ANALYSIS AND BIOMARKER EVALUATION: RANDOMIZED PHASE IB/II STUDY OF RILOTUMUMAB (AMG 102) OR GANITUMAB (AMG 479) WITH PANITUMUMAB VERSUS PANITUMUMAB ALONE IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC). Annals of Oncology. 22.
17.
Giebel, Sebastian, Jan Walewski, Elżbieta Nowara, et al.. (2010). Profilaktyka zajęcia ośrodkowego układu nerwowego u chorych na chłoniaka rozlanego z dużych komórek B. Rekomendacje Polskiej Grupy Badawczej Chłoniaków (PLRG). Nowotwory Journal of Oncology. 60(2). 161–161.
18.
Huszno, Joanna & Elżbieta Nowara. (2010). Farmakokinetyka i farmakogenetyka w systemowym leczeniu chorych na raka piersi. 6(4).
19.
Nowara, Elżbieta, et al.. (2008). ["Hand-foot" syndrome--after liposomal pegylated doxorubicin in patients with the ovarian cancer recurrence (own experiences)].. PubMed. 79(5). 332–7.
20.
Nowara, Elżbieta & Rafał Suwiński. (2005). [Time factor in radiotherapy and chemotherapy for small cell lung cancer].. PubMed. 73(1). 23–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth B. Somers Breakdown of academic impact, for papers by Xochiquetzal J. Geiger Breakdown of academic impact, for papers by Vamsi Parimi Breakdown of academic impact, for papers by Dimitra Grapsa Breakdown of academic impact, for papers by Li‐Chun Lu Breakdown of academic impact, for papers by E. Kutarska Breakdown of academic impact, for papers by Teresa Drudis Breakdown of academic impact, for papers by Iori Kisu Breakdown of academic impact, for papers by Mark Messing Breakdown of academic impact, for papers by Shin‐Wha Lee
Rankless by CCL
2026